Rocio García‐Carbonero
About
Rocio García‐Carbonero is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology.
According to data from OpenAlex, Rocio García‐Carbonero has authored 306 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 258 papers in Oncology, 101 papers in Pulmonary and Respiratory Medicine and 100 papers in Epidemiology. Recurrent topics in Rocio García‐Carbonero's work include Colorectal Cancer Treatments and Studies (118 papers), Neuroendocrine Tumor Research Advances (95 papers) and Lung Cancer Research Studies (78 papers). Rocio García‐Carbonero is often cited by papers focused on Colorectal Cancer Treatments and Studies (118 papers), Neuroendocrine Tumor Research Advances (95 papers) and Lung Cancer Research Studies (78 papers). Rocio García‐Carbonero collaborates with scholars based in Spain, United States and Italy. Rocio García‐Carbonero's co-authors include Jeffrey G. Supko, Luis Paz‐Ares, Amancio Carnero, Josep Tabernero, Takayuki Yoshino, Eric Van Cutsem, Jaume Capdevila, Fernando Rivera, Martyn Caplin and Ramón Salazar and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Rocio García‐Carbonero
297 papers receiving 9.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rocio García‐Carbonero Spain | 51 | 6.7k | 2.6k | 2.4k | 2.1k | 1.7k | 306 | 9.7k | ||
| Ramón Salazar Spain | 52 | 9.4k 1.4× | 5.3k 2.0× | 3.0k 1.3× | 1.9k 0.9× | 3.4k 2.0× | 249 | 13.3k | ||
| Rosine Guimbaud France | 34 | 7.7k 1.1× | 2.0k 0.7× | 1.5k 0.6× | 2.5k 1.2× | 445 0.3× | 178 | 9.5k | ||
| Daniel Morgensztern United States | 36 | 5.4k 0.8× | 1.9k 0.7× | 3.9k 1.6× | 4.5k 2.1× | 469 0.3× | 228 | 10.4k | ||
| Andrea Ardizzoni Italy | 56 | 8.4k 1.2× | 2.0k 0.8× | 3.6k 1.5× | 6.6k 3.1× | 523 0.3× | 471 | 13.1k | ||
| Manal M. Hassan United States | 45 | 5.9k 0.9× | 5.8k 2.2× | 2.6k 1.1× | 756 0.4× | 2.6k 1.5× | 159 | 10.3k | ||
| Pascal Hammel France | 65 | 12.1k 1.8× | 5.8k 2.2× | 1.8k 0.8× | 3.6k 1.7× | 2.3k 1.3× | 367 | 15.8k | ||
| David P. Kelsen United States | 72 | 8.9k 1.3× | 1.7k 0.6× | 3.1k 1.3× | 6.3k 3.0× | 650 0.4× | 292 | 14.6k | ||
| Howard S. Höchster United States | 56 | 8.1k 1.2× | 1.1k 0.4× | 2.4k 1.0× | 3.3k 1.6× | 364 0.2× | 342 | 12.0k | ||
| Shinichi Yachida Japan | 38 | 4.6k 0.7× | 1.3k 0.5× | 2.1k 0.9× | 1.6k 0.7× | 331 0.2× | 141 | 6.9k | ||
| Hedy L. Kindler United States | 61 | 8.4k 1.3× | 1.2k 0.5× | 3.6k 1.5× | 7.3k 3.5× | 534 0.3× | 400 | 16.1k |
Countries citing papers authored by Rocio García‐Carbonero
Since
Specialization
Citations
This map shows the geographic impact of Rocio García‐Carbonero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocio García‐Carbonero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocio García‐Carbonero more than expected).
Fields of papers citing papers by Rocio García‐Carbonero
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rocio García‐Carbonero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocio García‐Carbonero. The network helps show where Rocio García‐Carbonero may publish in the future.
Co-authorship network of co-authors of Rocio García‐Carbonero
This figure shows the co-authorship network connecting the top 25 collaborators of Rocio García‐Carbonero. A scholar is included among the top collaborators of Rocio García‐Carbonero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocio García‐Carbonero. Rocio García‐Carbonero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hernando, Jorge, Javier Molina‐Cerrillo, Rocio García‐Carbonero, et al.. (2025). Data from Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914). DIGITAL.CSIC (Spanish National Research Council (CSIC)).
2.
Martínez, María Carmen Riesco, Jaume Capdevila, Vicente Alonso, et al.. (2024). Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature Communications. 15(1). 6753–6753.
3.
Lenz, Heinz‐Josef, Sara Lonardi, Elena Élez, et al.. (2024). Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Expanded efficacy analysis from CheckMate 8HW.. Journal of Clinical Oncology. 42(16_suppl). 3503–3503.
4.
Lamberti, Giuseppe, Francesco Panzuto, Marianne Pavel, et al.. (2024). Gastric neuroendocrine neoplasms. Nature Reviews Disease Primers. 10(1). 25–25.
5.
García‐Carbonero, Rocio, Carles Pericay, Ana Fernández Montés, et al.. (2023). Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain. Clinical & Translational Oncology. 26(4). 864–871.
6.
García‐Carbonero, Rocio, et al.. (2023). Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?. Endocrine Reviews. 44(4). 724–736.
7.
Romesser, Paul B., Jaume Capdevila, Rocio García‐Carbonero, et al.. (2023). A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clinical Cancer Research. 30(4). 695–702.
8.
Soldevilla, Beatriz, Sonia Molina‐Pinelo, Marta Benavent, et al.. (2023). MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms. Molecular Oncology. 17(4). 582–597.
9.
Martínez, María Carmen Riesco, et al.. (2022). Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives. Current Treatment Options in Oncology. 23(9). 1320–1337.
10.
Koopman, Miriam, Carmine Pinto, G. Bodoky, et al.. (2022). Rationale and Design of the PROMETCO Study: A Real-World, Prospective, Longitudinal Cohort on the Continuum of Care of Metastatic Colorectal Cancer From a Clinical and Patient Perspective. Future Oncology. 18(11). 1313–1320.
11.
Salvia, Anna La, et al.. (2021). Chemotherapy in NEN: still has a role?. Reviews in Endocrine and Metabolic Disorders. 22(3). 595–614.
12.
Vidal, Joana, David Casadevall, Beatríz Bellosillo, et al.. (2021). Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial. Clinical Cancer Research. 27(10). 2890–2898.
13.
Salvia, Anna La, et al.. (2018). HER2-targeted therapy: an emerging strategy in advanced colorectal cancer. Expert Opinion on Investigational Drugs. 28(1). 29–38.
14.
González‐Flores, Encarnación, Rafael Serrano del Rosal, Isabel Sevilla, et al.. (2018). SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018). Clinical & Translational Oncology. 21(1). 55–63.
15.
García‐Carbonero, Rocio, Anja Rinke, Juan W. Valle, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy. Neuroendocrinology. 105(3). 281–294.
16.
Dienstmann, Rodrigo, Amita Patnaik, Rocio García‐Carbonero, et al.. (2015). Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer. Cancer Discovery. 5(6). 598–609.
17.
Gómez-Martín, Carlos, Fernando López‐Ríos, Jorge Aparicio, et al.. (2014). A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond. Cancer Letters. 351(1). 30–40.
18.
Estévez-García, Purificación, Sonia Molina‐Pinelo, Sandra Muñoz-Galván, et al.. (2013). Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma. Clinical Cancer Research. 19(14). 3925–3935.
19.
Tabernero, Josep, Rocio García‐Carbonero, James T. Cassidy, et al.. (2013). Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial. Clinical Cancer Research. 19(9). 2541–2550.
20.
García‐Carbonero, Rocio, Judith Manola, Michael V. Seiden, et al.. (2004). Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy. Journal of Clinical Oncology. 22(8). 1480–1490.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ramón Salazar Breakdown of academic impact, for papers by Rosine Guimbaud Breakdown of academic impact, for papers by Daniel Morgensztern Breakdown of academic impact, for papers by Andrea Ardizzoni Breakdown of academic impact, for papers by Manal M. Hassan Breakdown of academic impact, for papers by Pascal Hammel Breakdown of academic impact, for papers by David P. Kelsen Breakdown of academic impact, for papers by Howard S. Höchster Breakdown of academic impact, for papers by Shinichi Yachida Breakdown of academic impact, for papers by Hedy L. Kindler